Skip to main content
Home/PTCB/Study Guides/Error Prevention Strategies

Error Prevention Strategies

Error prevention strategies, including Tall Man lettering, separating inventory, leading and trailing zeros, bar code usage, and limiting error-prone abbreviations.

4% of PTCE exam·20 practice questions

Error prevention strategies account for 4.0% of the PTCE. This topic tests the concrete, system-level tools pharmacies use to stop errors before they reach a patient: Tall Man lettering, inventory separation, correct use of leading and trailing zeros, bar-code scanning, and the elimination of error-prone abbreviations. Each of these is a named, testable safeguard — know what it is and the specific error it prevents.

Tall Man Lettering

Tall Man lettering writes the distinguishing portion of a look-alike drug name in capital letters to force the eye to notice the difference — for example predniSONE vs. prednisoLONE, hydrALAZINE vs. hydrOXYzine, and DOBUTamine vs. DOPamine. The FDA began this with its Name Differentiation Project in 2001, and ISMP has maintained an expanded list of recommended Tall Man pairs since 2008. The technique specifically targets LASA errors at the point of selection and labeling.

Tall Man lettering capitalizes the letters that DIFFER between two similar names, not the ones they share.

Leading and Trailing Zeros

Two zero rules prevent thousand-fold dosing errors. Always use a leading zero before a decimal point (write 0.5 mg, never .5 mg) so a missed decimal point isn't read as "5 mg." Never use a trailing zero after a whole number (write 5 mg, never 5.0 mg) because a missed decimal point turns "5.0" into "50." Both the naked decimal (.5) and the trailing zero (5.0) appear on the Joint Commission Official "Do Not Use" list.

Leading zero: ALWAYS (0.5 mg). Trailing zero: NEVER (5 mg, not 5.0 mg).

Error-Prone Abbreviations

The Joint Commission Official "Do Not Use" list (created 2004) prohibits: U/u (mistaken for 0, 4, or cc — write "unit"), IU (mistaken for IV or 10 — write "International Unit"), QD/q.d. and QOD/q.o.d. (confused with each other — write "daily" and "every other day"), trailing zeros and missing leading zeros, and MS/MSO4/MgSO4 (MS can mean either morphine sulfate or magnesium sulfate; spell both out). ISMP publishes a broader list of additional error-prone abbreviations, such as writing "mcg" instead of "µg."

MS is banned because it can mean morphine sulfate OR magnesium sulfate — two completely different drugs.

Bar Coding and Inventory Separation

Bar-code scanning verifies the National Drug Code (NDC) of the product against what the system expects, catching wrong-drug and wrong-strength picks that a human eye can miss; in hospitals this extends to bar-code medication administration (BCMA) at the bedside. Separating inventory — shelving look-alike or sound-alike products apart, adding shelf dividers, and flagging high-alert items — reduces the chance of grabbing the wrong bottle. "Shelf talkers" and auxiliary warning labels reinforce the separation.

Must-Know for the Exam

  • Tall Man lettering capitalizes the differing letters (predniSONE vs. prednisoLONE) to prevent LASA errors
  • FDA Name Differentiation Project began 2001; ISMP Tall Man list since 2008
  • Always use a leading zero: 0.5 mg, never .5 mg
  • Never use a trailing zero: 5 mg, never 5.0 mg
  • Joint Commission "Do Not Use" list created 2004: U, IU, QD, QOD, trailing zero, lack of leading zero, MS/MSO4/MgSO4
  • Write "unit" not U, and "International Unit" not IU
  • Bar-code scanning verifies the NDC to catch wrong-drug/wrong-strength errors
  • Separate look-alike/sound-alike products on the shelf to prevent selection errors

Common Exam Mistakes

  • Capitalizing the shared letters of two drug names instead of the letters that differ
  • Writing .5 mg instead of 0.5 mg (a missing leading zero risks a 10-fold overdose)
  • Writing 5.0 mg instead of 5 mg (a trailing zero risks a 10-fold overdose)
  • Using "U" for units — it is read as 0, 4, or cc
  • Assuming MS unambiguously means morphine sulfate when it can also mean magnesium sulfate
  • Trusting a visual name match instead of scanning the bar code / NDC

Quiz yourself on Error Prevention Strategies

Test what you just read — instant feedback on every question.

Start Error Prevention Strategies Practice Quiz →

Key Concepts — Part 1

1. Why do pharmacy safety guidelines recommend against writing a trailing zero, such as '5.0 mg' instead of '5 mg'?

If the decimal point is missed or not seen clearly, '5.0' can be misread as '50', causing a tenfold overdose

A missed decimal point turns '5.0 mg' into '50 mg' -- a dangerous tenfold error -- so ISMP recommends writing whole numbers without a trailing zero. This is a genuine patient safety rule, not a style preference, and it applies broadly, not just to controlled substances.

2. Why should a leading zero always be used for doses less than one, such as writing '0.5 mg' instead of '.5 mg'?

Without the leading zero, a faint or missed decimal point could cause '.5 mg' to be misread as '5 mg', a tenfold overdose

If the decimal point in '.5 mg' is missed, it can be read as '5 mg' -- a tenfold overdose -- so a leading zero ('0.5 mg') makes the decimal point far more visible and reduces that risk. This applies to written and electronic orders alike and has nothing to do with controlled substance status.

3. A written order includes the abbreviation 'MSO4 10mg.' What is the concern with this abbreviation, and what should the technician do?

MSO4 could be confused between morphine sulfate and magnesium sulfate; the technician should flag it for clarification rather than assume which drug is meant

MSO4 (intended as morphine sulfate) and MgSO4 (magnesium sulfate) are both sometimes abbreviated similarly and are on ISMP's error-prone abbreviation list; they are very different drugs with very different risks, so the order should be clarified with the prescriber/pharmacist rather than guessed at. Patients are not the appropriate source to resolve a prescribing ambiguity.

4. Why is the abbreviation 'U' for 'units' (e.g., '10U' for insulin) discouraged on prescriptions and orders?

The 'U' can be mistaken for a zero or the number 4, turning '10U' into '100' or '104', a serious dosing error

A handwritten or poorly printed 'U' can look like a zero or the number 4, which can turn a safe insulin dose into a massive overdose -- this is why ISMP's Do Not Use list recommends spelling out 'units' in full. This is a genuine, well-documented risk, not a matter of writing speed.

5. What is the primary risk of using the abbreviation 'QD' (intended to mean 'once daily')?

It can be misread as 'QID' (four times daily) or mistaken for 'OD' (right eye), leading to a dosing frequency or route error

'QD' is on the error-prone abbreviation list because it can be misread as 'QID' (four times daily) or confused with 'OD' (right eye, an ophthalmic abbreviation), both of which could lead to serious frequency or route errors; the safer practice is to write 'daily' in full. It is not specific to topical drugs, and it has nothing to do with weekly dosing defaults.

6. What is the primary safety purpose of scanning a medication's bar code before it is placed into a dispensing vial?

It verifies that the drug, strength, and often the patient match the prescription, catching mismatches before the medication reaches the patient

Bar code scanning cross-checks the physical product against the prescribed order (and sometimes the patient) as an added safety layer to catch wrong-drug or wrong-strength selections before dispensing. It does not calculate copays, is not a substitute for pharmacist verification, and its safety role goes beyond expiration tracking.

7. While restocking a shelf, a technician scans a bottle and the system indicates the bar code does not match the bin's labeled product. What should the technician do?

Stop, do not place the item in that bin, and investigate or alert the pharmacist about the mismatch

A bar code mismatch during restocking is exactly the kind of signal that prevents future dispensing errors -- stopping to investigate (rather than overriding or guessing) keeps a wrong product from being shelved in the wrong bin. Relabeling without verifying which product is actually correct could institutionalize the error rather than fix it.

8. What is the main reason high-alert and LASA medications are stored in physically separate, non-adjacent locations rather than alphabetically together?

Physical separation reduces the chance that a technician grabs the wrong product due to visual similarity or shelf proximity

Storing look-alike or high-alert drugs apart from their alphabetical neighbors reduces the odds of accidentally grabbing the wrong product due to shelf proximity -- a well-established ISMP recommendation. It is a best practice rather than a blanket federal mandate, and alphabetical storage itself isn't prohibited for other drugs.

9. vinCRIStine and vinBLAStine are formatted with Tall Man lettering mainly because:

They are both chemotherapy agents with similar names but very different dosing, and a mix-up has caused fatal errors in the past

Vincristine and vinblastine are both vinca alkaloid chemotherapy drugs with similar names but very different dosing (vincristine overdoses, in particular, have caused deaths), making Tall Man lettering (vinCRIStine/vinBLAStine) an important visual safety cue. They are not the same drug, and neither is a low-risk antihistamine.

10. A pharmacy bin displays a bright 'High-Alert Medication' auxiliary sticker. What is this sticker intended to prompt?

Extra caution and verification when selecting, filling, or checking that product, given its potential for serious harm if an error occurs

High-alert stickers exist to visually cue staff to slow down and apply extra verification (e.g., independent double-checks) for medications where an error could cause serious harm. They do not mean fewer checks, OTC status, or discontinuation.

Key Concepts — Part 2

1. Why is an independent double-check (e.g., a second staff member separately verifying a high-alert medication dose) considered an effective error prevention strategy?

A second, independent reviewer is more likely to catch an error that the first person missed, since they are not anchored by the same assumptions

Independent double-checks work because the second checker reviews the medication separately from the first, without seeing the first person's work, reducing the chance both people make or overlook the same mistake. It is a recognized, evidence-supported safety layer, not a redundant slowdown, and it complements rather than replaces bar code scanning.

2. A pharmacy chooses to stock only one strength of a concentrated electrolyte solution for compounding rather than multiple strengths. What error prevention benefit does this offer?

It reduces the chance of selecting the wrong concentration during a high-risk compounding step

Standardizing to a single available concentration for a high-risk product removes the possibility of grabbing the wrong strength during preparation -- a common ISMP-recommended strategy for concentrated electrolytes. It is a safety measure, not a way to avoid stocking high-alert drugs or skip verification.

3. A technician wants to override a safety alert on an automated dispensing cabinet (ADC) to quickly remove a medication for an urgent request. What is the appropriate approach?

Overrides should be limited to genuine emergencies and used cautiously, since they bypass built-in safety checks meant to catch errors

ADC override features exist for genuine emergencies but bypass normal verification steps (like pharmacist review), so they carry inherent risk and should be used sparingly and cautiously, not as a routine convenience. They are legal and available in true emergencies, but the ADC does not eliminate the risk of pulling the wrong item during an override.

4. Why is the abbreviation 'cc' discouraged in favor of writing 'mL' on prescriptions and labels?

'cc' can be misread as 'u' (units) or as '00', creating confusion about the quantity or measurement intended

Handwritten 'cc' can be misread as 'u' (units) or '00', creating dosing ambiguity, which is why ISMP recommends using 'mL' instead. Cc and mL are actually equivalent volume measurements (not different precision levels), and this concerns liquid measurement, not solid dosage forms.

5. A technician takes a verbal order for a new prescription over the phone from a prescriber's office. What error prevention step should the technician take before ending the call?

Read the order back to the caller to confirm the drug, strength, quantity, and directions were heard correctly

Reading back a verbal order confirms that what was heard matches what was intended, catching mishearings before they become dispensing errors -- a standard verbal-order safety practice. Skipping confirmation or guessing at unclear details increases error risk rather than reducing it.

6. Why do many pharmacies designate a 'quiet zone' or minimize interruptions during the medication-filling step?

Interruptions and distractions increase the likelihood of selecting the wrong drug, dose, or patient during a high-attention task

Interruptions during filling are a well-documented contributor to selection errors, since attention is diverted mid-task; minimizing distractions during this step is a recognized error-prevention strategy, not merely a customer service measure. It applies broadly to the filling process, not just hazardous compounding.

7. A pharmacy places hydrOXYzine and hydrALAzine bins with Tall Man lettering directly next to each other on the shelf. What additional error prevention step should still be taken?

Physically separate the two bins despite the Tall Man lettering, since shelf proximity remains a risk even with visual differentiation

Tall Man lettering reduces (but does not eliminate) the risk of misreading a name; keeping known LASA drugs physically apart adds a second, independent layer of protection against grabbing the wrong bin. Removing the lettering or combining the drugs into one bin would increase risk, not reduce it.

8. What is the primary safety benefit of scanning a product's bar code during receiving/restocking, before it is placed into a shelf bin?

It verifies the product matches the intended bin location, preventing a mislabeled or wrong item from being shelved where staff expect a different drug

Scanning during restocking confirms the item actually matches its intended bin before it's shelved, preventing a downstream selection error where staff trust the bin label without rechecking. It's a safety check at the storage stage, not an automatic reordering tool or exclusively a controlled-substance function, and it doesn't replace expiration checks.

9. What do the 'leading zero' and 'trailing zero' rules have in common as error prevention strategies?

Both are aimed at making the decimal point in a dose clearly visible, since a missed decimal point in either direction can cause a tenfold dosing error

The leading zero rule (0.5 mg, not .5 mg) and the trailing zero rule (5 mg, not 5.0 mg) both exist to make sure a decimal point is never missed or misread, since either mistake can cause a tenfold dosing error. Neither rule is limited to controlled substances or is purely cosmetic.

10. A technician is asked to relabel a stock bin after receiving a shipment. Which practice best supports error prevention at this step?

Scanning the product's bar code to confirm it matches the intended label before applying it to the bin

Verifying the actual product against its bar code before labeling a bin closes the loop on accurate shelf identification, which is foundational to preventing downstream selection errors. Relying on appearance alone or skipping verification is exactly how mislabeled bins (and later LASA errors) occur.

Ready to test your knowledge?

Practice questions with instant feedback and explanations.

Take a PTCB Practice Test →
100% freeNo signup requiredInstant explanations